Rankings
▼
Calendar
BMRN Q1 2021 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena
BMRN
BioMarin Pharmaceutical Inc.
$12B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$486M
-3.2% YoY
Gross Profit
$366M
75.3% margin
Operating Income
$25M
5.2% margin
Net Income
$17M
3.6% margin
EPS (Diluted)
$0.09
QoQ Revenue Growth
+7.5%
Cash Flow
Operating Cash Flow
$114M
Free Cash Flow
$85M
Stock-Based Comp.
$50M
Balance Sheet
Total Assets
$5.8B
Total Liabilities
$1.6B
Stockholders' Equity
$4.2B
Cash & Equivalents
$667M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$486M
$502M
-3.2%
Gross Profit
$366M
$391M
-6.3%
Operating Income
$25M
$105M
-76.1%
Net Income
$17M
$81M
-78.7%
Revenue Segments
Royalty And Other
$18M
100%
Geographic Segments
UNITED STATES
$208M
43%
Europe
$162M
33%
Latin America
$60M
12%
Rest Of World
$56M
12%
← FY 2021
All Quarters
Q2 2021 →